Artelo Biosciences Inc ARTL
NASDAQ · United States · Health Technology
$3.83-0.21 (-5.20%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Price reaction |
|---|---|---|---|---|---|
| Q2 2026 | 2026-08-13 | -8.01 | -6.48 | -23.6% | +7.8%$6.60→$7.11 |
| Q4 2025 | 2026-02-24 | -1.08 | -42.39 | +97.5% | -2.4%$33.48→$32.67 |
| Q3 2025 | 2025-11-12 | -107.19 | -22.14 |
| -384.1% |
| -8.2%$52.92→$48.60 |
| Q2 2025 | 2025-08-13 | -151.47 | -113.13 | -33.9% | — |
| Q1 2025 | 2025-05-13 | -116.64 | -21.06 | -453.8% | — |
| Q4 2024 | 2025-03-03 | -189.54 | -61.56 | -207.9% | — |
| Q2 2024 | 2024-08-13 | -121.50 | -137.16 | +11.4% | — |
| Q1 2024 | 2024-05-13 | -126.36 | -170.91 | +26.1% | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.